Drug intelligence / Profile preview

trimegestone

Development stage
Phase 4
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Trimegestone is a synthetic progestin of the 19-norpregnane class, developed primarily for use in menopausal hormone therapy. It acts as a highly potent and selective agonist of the progesterone receptor, with an affinity significantly greater than that of natural progesterone. Trimegestone exhibits minimal activity at androgen, glucocorticoid, and mineralocorticoid receptors and has no estrogenic activity. Its primary clinical use is in combination with estrogens (such as estradiol) for postmenopausal hormone replacement therapy to provide endometrial protection and manage climacteric symptoms. The drug does not negate the beneficial effects of estrogen on lipid profiles and demonstrates favorable bleeding patterns compared to other progestins[2][3][5][6].

Brand names
OndevaTotelle
Other names
trimegestone74513-62-5Trimegestone [INN]Ru-27987Ru27987Ru 27987
02

Targets

PR (Progesterone receptor)

Beyond the preview

Go deeper on trimegestone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on trimegestone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call